18.81 -0.08 (-0.42%)
GHDX
Stock Details
Last Trade:18.81 Change:-0.08 (-0.42%) Prev Close:18.89 Open: 19.00 Days Range:18.76 – 19.00 52 Week Range: 15.81 - 27.22 Volume:120414 P/E: N/AEPS:-0.33
View AllRecent Alerts 03/19/10
Recent Alert on 03/08/10 at 4:41pm
Genomic Health (GHDX) Publishes Positive Data on Oncotype DX Test
Genomic Health (GHDX) Publishes Positive Data on Oncotype DX Test
Genomic Health, Inc. (NASDAQ: GHDX) today announced the publication of positive results from a large international study which demonstrated that the Oncotype DX breast cancer Recurrence Score (RS) result is a significant independent predictor of... Read More
Recent Alert on 03/08/10 at 4:41pm
Genomic Health (GHDX) Publishes Positive Data on Oncotype DX Test
Genomic Health (GHDX) Publishes Positive Data on Oncotype DX Test
Recent Alert on 03/02/10 at 1:14pm
Ladenburg Thalmann Initiates Coverage on Genomic Health (GHDX) with a Buy
Ladenburg Thalmann Initiates Coverage on Genomic Health (GHDX) with a Buy
Recent Alert on 02/26/10 at 8:36am
Genomic Health (GHDX) Announces Results of Oncotype DX Breast Cancer Test in Asia Pacific Countires
Genomic Health (GHDX) Announces Results of Oncotype DX Breast Cancer Test in Asia Pacific Countires
Recent Alert on 02/26/10 at 8:36am
Genomic Health (GHDX) Announces Results of Oncotype DX Breast Cancer Test in Asia Pacific Countires
Genomic Health (GHDX) Announces Results of Oncotype DX Breast Cancer Test in Asia Pacific Countires
View AllRecent Press Releases
No Recent Press Releases Available
View AllRecent SEC Filings
SEC Filing on 03/16/10 at 7:37pm
Form 4 GENOMIC HEALTH INC For: Mar 15 Filed by: Popovits Kimberly J
Form 4 GENOMIC HEALTH INC For: Mar 15 Filed by: Popovits Kimberly J
View AllRecent Blog Posts
Blog Posts on 10/14/09 at 6:47am
With Promising Cancer Drugs, Genomic Must Still Diversify Its Pipeline
With Promising Cancer Drugs, Genomic Must Still Diversify Its Pipeline